Chong Kun Dang Pharmaceutical Corp. (185750.KS) KSC

Currency In KRW

AD

Valuation

Market Cap1.09T
Enterprise Value1.24T
P/E Ratio11.08
PEG Ratio0.36
Price/Sales Ratio0.49
Price/Book Ratio0.91
Enterprise/Revenue0.63
Enterprise/EBITDA9.08

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.04
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.08

Income Statement

Revenue1.69T
Revenue/Share129,157.38
Gross Profit517.23B
EBITDA125.37B
Net Income77.83B
Diluted EPS5,845.54

Balance Sheet

Total Cash329.3B
Total Cash/Share23,857.12
Total Debt437.44B
Total Debt/Equity0.43
Current Ratio2.04
Book Value Per Share73,776.12

Price History

52-Week Change-18.54
52-Week High98,100
52-Week Low63,000
Moving Average 50 Days68,194
Moving Average 200 Days80,279

Statistics

Average Volume25,567
Shares Outstanding13.18M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate500
Trailing Annual Dividend Yield0.75
Payout Ratio0.08
Last Split Factor21:20
Last Split DateDecember 27, 2024
AD